Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative inhaled salbutamol for prevention of perioperative respiratory adverse events in children undergoing tonsillectomy
ACTRN12614000739617Phase 4Completed
- Sponsor
- Princess Margaret Cancer Centre
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in respiratory complication comparing Inhaled salbutamol with Inhaled placebo (2 arms). Primary endpoint: Incidence of perioperative respiratory adverse events. Started Jul 2014; status: completed.
02
Drugs
salbutamol
03
Conditions
respiratory complication
Beyond the preview
Go deeper on ACTRN12614000739617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000739617.